Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: Role of hepatic triglyceride storage
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Epidemiological studies have demonstrated a strong link between increased visceral fat and metabolic syndrome. In rodents, removal of intra-abdominal but non-visceral fat improves insulin sensitivity and glucose homeostasis, though previous studies make an imprecise comparison to human physiology because actual visceral fat was not removed. We hypothesize that nutrient release from visceral adipose tissue may have greater consequences on metabolic regulation than nutrient release from non-visceral adipose depots since the latter drains into systemic but not portal circulation. To assess this we surgically decreased visceral white adipose tissue (~0.5 g VWATx) and compared the effects to removal of non-visceral epididymal fat (~4 g; EWATx), combination removal of visceral and non-visceral fat (~4.5 g; EWATx/VWATx) and sham-operated controls, in chow-fed rats. At 8 weeks after surgery, only the groups with visceral fat removed had a significantly improved glucose tolerance, although 8 times more fat was removed in EWATx compared with VWATx. This suggests that mechanisms controlling glucose metabolism are relatively more sensitive to reductions in visceral adipose tissue mass. Groups with visceral fat removed also had significantly decreased hepatic lipoprotein lipase (LPL) and triglyceride content compared with controls, while carnitine palmitoyltransferase (CPT-1A) was decreased in all fat-removal groups. In a preliminary experiment, we assessed the opposite hypothesis; i.e., we transplanted excess visceral fat from a donor rat to the visceral cavity (omentum and mesentery), which drains into the hepatic portal vein, of a recipient rat but observed no major metabolic effect. Overall, our results indicate surgical removal of intra-abdominal fat improves glucose tolerance through mechanism that may be mediated by reductions in liver triglyceride.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643 · cited 7×
“There was no difference among groups in blood glucose concentrations following insulin injection (ITT) at 5 or 9 weeks (Fig.”
MethodInfluentialEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Obesity-induced accumulation of intrahepatic triglyceride content is a highly-correlated indicator of metabolic dysfunction [11], as are increased levels of several adipose-derivedhormones and/or cytokines [12], but the explicit association between increased visceral adipose mass and metabolic dysregulation is not com…”
BackgroundRemoval of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
Gabriely, I., Ma, X. H., Yang, X. M., Atzmon, G., Rajala, M. W., Berg, A. H., Scherer, P., Rossetti, L., & Barzilai, N. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2951 · Cited by 563
Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538 · cited 1×
“Indeed this area of research is controversial given that deep subcutaneous adipose tissue has also been independently associated with metabolic abnormalities [55].”
BackgroundXu, J., Nakamura, M. T., Cho, H. P., & Clarke, S. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23577 · Cited by 499 · cited 1×
“In thismodel, chronic exposure of the liver to elevated free-fatty acids (FFAs) released from visceral adipocytes promotes liver gluconeogenesis [2,5,6], reduces enzymes involved in FFA oxidation, and increases hepatic lipogenesis [7,8] and liver triglyceride content [9], all of which subsequently contribute to system…”
BackgroundDobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., & McGarry, J. D. (2001) · Diabetes · doi:10.2337/diabetes.50.1.123 · Cited by 315 · cited 1×
“Although data suggest that prolonged 95% suppression of hepatic CPT-1 via CPT-1 inhibitor in lean rats causes a ~100% increase in triglyceride concentration [47], other hepatic lipid regulatory processes must be taken into account with our non-pharmacological model such as alterations in de novo lipogenesis/esterifica…”
BackgroundSexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis
Shi, H., Strader, A. D., Sorrell, J. E., Chambers, J. B., Woods, S. C., & Seeley, R. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00704.2007 · Cited by 85 · cited 1×
“As previously described [32] RNAeasy columns (QIAGEN, Valencia, CA) were used to isolate RNA according to the manufacturer's instructions.”
MethodMetabolic response to localized surgical fat removal in nonobese women
Lambert, E. V., Hudson, D. A., Bloch, C. E., & Koeslag, J. H. (1991) · Aesthetic Plastic Surgery · doi:10.1007/bf02273842 · Cited by 28 · cited 1×
“excised areas [39,40], and epididymal fat removal in Siberian hamsters results in significant increases in subcutaneous and intraabdominal adipose deposition [For review see [41]].”
BackgroundYost, T. J., Rodgers, C. M., & Eckel, R. H. (1993) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-199311000-00016 · Cited by 27
Cited by
Adipose tissue in control of metabolism
Luo, L., & Liu, M. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0211 · Cited by 693
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues
Pellegrinelli, V., Carobbio, S., & Vidal-Puig, A. (2016) · Diabetologia · doi:10.1007/s00125-016-3933-4 · Cited by 432
The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity
Jeffery, E., Wing, A., Holtrup, B., Sebo, Z., Kaplan, J. L., Saavedra-Peña, R., Church, C. D., Colman, L., Berry, R., & Rodeheffer, M. S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.012 · Cited by 352
“…of these depots in mice differ from humans, these mouse depots impact metabolism similarly to human visceral adipose tissues (Barzilai et al., 1999; Foster et al., 2010, 2011; Gabriely and Barzilai, 2003) and gluteofemoral adipose tissue (Foster et al., 2013; Tran et al., 2008), respectively.”
Visceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 265
White adipose tissue dysfunction in obesity and aging
Reyes-Farias, M., Fos-Domenech, J., Serra, D., Herrero, L., & Sánchez-Infantes, D. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114723 · Cited by 250
Metadata
- Authors
- Foster, M. T., Shi, H., Seeley, R. J., & Woods, S. C.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 104
- Issue
- 5
- Pages
- 845-854
- ISSN
- 0031-9384 (ISSN-L)
- OpenAlex
- W2004831862
- Cited by
- 58
- References
- 10
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.